Long-term prognosis after deep venous thrombosis

2008 ◽  
Vol 7 (6) ◽  
pp. 586-590
Author(s):  
Hadia Shbaklo ◽  
Susan R Kahn
Keyword(s):  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Long Term Prognosis

Long-term prognosis after deep venous thrombosis

2008 ◽  
Vol 15 (5) ◽  
pp. 494-498 ◽  
Author(s):  
Hadia Shbaklo ◽  
Susan R Kahn
Keyword(s):  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Long Term Prognosis

Impact of Asymptomatic Pulmonary Embolism on the Long-Term Prognosis of Patients with Deep Venous Thrombosis

2016 ◽  
Vol 43 (01) ◽  
pp. 024-029
Author(s):  
Nina Vene ◽  
Katarina Košmelj ◽  
Alenka Mavri ◽  
Anja Boc
Keyword(s):  
Pulmonary Embolism ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Long Term Prognosis

scholarly journals Long-term Results after Transfemoral Venous Thrombectomy for Iliofemoral Deep Venous Thrombosis

2010 ◽  
Vol 40 (1) ◽  
pp. 134-138 ◽  
Author(s):  
C. Lindow ◽  
A. Mumme ◽  
G. Asciutto ◽  
B. Strohmann ◽  
T. Hummel ◽  
...  
Keyword(s):  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Long Term Results ◽  
Venous Thrombectomy

Catheter-related deep venous thrombosis in children with hemophilia

Blood ◽  
2001 ◽  
Vol 98 (6) ◽  
pp. 1727-1731 ◽  
Author(s):  
Janna M. Journeycake ◽  
Charles T. Quinn ◽  
Kim L. Miller ◽  
Joy L. Zajac ◽  
George R. Buchanan
Keyword(s):  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Central Venous Catheters ◽  
Catheter Placement ◽  
Central Venous ◽  
Radiographic Evidence ◽  
Catheter Dysfunction ◽  
The Mean ◽  
Clinical Problems

Abstract Central venous catheters (CVCs) are a common adjunct to hemophilia therapy, but the risk of CVC-related deep venous thrombosis (DVT) in hemophiliacs is not well defined. In a previous study, 13 patients with CVCs had no radiographic evidence of DVT. However, recent abstracts and case studies demonstrate that DVT does occur. Therefore, this study sought to determine the frequency of DVT in children with hemophilia and long-term CVCs and to correlate venographic findings with clinical features. All hemophilia patients with tunneled subclavian CVCs in place for 12 months or more were candidates for evaluation. Patients were examined for physical signs of DVT and questioned about catheter dysfunction. Contrast venograms were obtained to identify DVT. Fifteen boys with severe hemophilia were evaluated, including 9 from the initially studied group of 13. Eight patients had evidence of DVT, 5 of whom previously had normal venograms. Five of 15 patients had clinical problems related to the CVC, all of whom had DVT. Four of 15 patients had suggestive physical signs; 3 had DVT. The mean duration of catheter placement for all patients was 57.5 months (range, 12-102 months). For patients with DVT, the mean duration was 66.6 ± 7.5 months, compared to 49.5 ± 7.2 months for patients without DVT (P = .06). No patient whose CVC was in place fewer than 48 months had an abnormal venogram. Many hemophilia patients with CVCs develop DVT of the upper venous system, and the risk increases with duration of catheter placement.

The Values of β-TG During the Anticoagulant Therapy in Patients with Venous Thrombosis and Myocardial Infarction

1979 ◽  
Author(s):  
A. Lucic ◽  
R. Borota ◽  
Z. Radujkov
Keyword(s):  
Myocardial Infarction ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Anticoagulant Therapy ◽  
The Other ◽  
Prothrombin Activity ◽  
Normal Concentration ◽  
Preliminary Results ◽  
Other Hand

In 38 patients with deep venous thrombosis and 52 patients with myocardial infarction who were on long term anticoagulant therapy, the estimations of β-TG have been done by radioimmunoassay using a kit developed by the Radiochemical Centre, Amersham, England. In the group of patients with deep venous thrombosis, the increased values of β-TG /values which were higher than 80 ng/ml /have been established in 47,3% of the cases and among the patients with myocardial infarction, in 73% of the cases. From the total of 56 patients with increased level of β-TG, in 50 patients the level of prothrombin activity was higher than 20%. On the other hand, in patients with normal concentration of β-TG, the level of prothrombin activity was usually lower than 20%. Our preliminary results suggest the possible use of estimation of β-TG as an important supplementary parameter for evaluation of a substantial efficasy of applied anticoagulant therapy.

scholarly journals An unusual case of deep venous thrombosis in a young patient: congenital absence of the infrarenal portion of the inferior vena cava

2019 ◽  
Vol 2019 (6) ◽  
Author(s):  
Thomas Osborne ◽  
Frances Sheehan
Keyword(s):  
Inferior Vena Cava ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Inferior Vena ◽  
Vena Cava ◽  
Congenital Absence ◽  
Current Evidence ◽  
Established Risk Factor ◽  
The Right

Abstract Deep venous thrombosis (DVT) is a commonly encountered diagnosis in clinical practice with a variety of well-established risk factors. Congenital absence of the inferior vena cava (IVC) is an extremely rare but established risk factor for DVT. Patients who develop DVTs are at high risk of long-term complications, including DVT recurrence and post-thrombotic syndrome. Here we report a rare case of a 27-year-old female who presented with an extensive DVT of the right lower extremity secondary to complete absence of the infrarenal portion of the IVC, confirmed on computed tomography. There is little consensus regarding the appropriate management of this patient population, and a brief review of the current evidence follows.

scholarly journals Long-term prognostic analysis of early interventional therapy for lower extremity deep venous thrombosis

2016 ◽  
Vol 12 (6) ◽  
pp. 3545-3548 ◽  
Author(s):  
Qiang Li ◽  
Zongxue Yu ◽  
Jinjun Wang ◽  
Xiao Chen ◽  
Lin Li
Keyword(s):  
Lower Extremity ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Interventional Therapy ◽  
Prognostic Analysis
Sign in / Sign up

Export Citation Format

Share Document